Abstract:Chemotherapy drugs themselves may act as stressors to induce adaptive responses to promote the chemoresistance of cancer cells. Our previous research showed that sirtuin 1 (SIRT1) was overexpressed in pancreatic cancer patients and deregulation of SIRT1 with RNAi could enhance chemosensitivity. Thus, we hypothesized that SIRT1 might facilitate chemoresistance in pancreatic cancer cells through regulating the adaptive response to chemotherapy-induced stress. In the present study, SIRT1 in PANC-1, BXPC-3, and ASPC-1 cells was upregulated after treatment with gemcitabine. Moreover, the decrease in SIRT1 activity with special inhibitor EX527 had a synergic effect on chemotherapy with gemcitabine in PANC-1 and ASPC-1 cell lines, which significantly promoted apoptosis, senescence, and G0 /G1 cycle arrest. Western blot results also showed that SIRT1, acetylated-p53, FOXO3a, and p21 were upregulated after combined treatment, whereas no obvious change was evident in total p53 protein. To further confirm the role of SIRT1 in clinical chemotherapy, SIRT1 was detected in eight pancreatic cancer tissues acquired by endoscopy ultrasonography guided fine needle aspiration biopsy before and after chemotherapy. Compared to before chemotherapy, SIRT1 was significantly increased after treatment with gemcitabine in six cases. Thus, our results indicated a special role for SIRT1 in the regulation of adaptive response to chemotherapy-induced stress, which is involved in chemoresistance. Moreover, it indicates that blocking SIRT1 activity with targeting drugs might be a novel strategy to reverse the chemoresistance of pancreatic cancer.

Regulation of SIRT1 activity by genotoxic stress.

A Divergent Role of the SIRT1-TopBP1 Axis in Regulating Metabolic Checkpoint and DNA Damage Checkpoint.

Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress.

SIRT1 Involved in the Regulation of Alternative Splicing Affects the DNA Damage Response in Neural Stem Cells.

Molecular Mechanisms Of A Disease Susceptibility Variant Of Sirt1: Genotoxic Stress-Induced, Ctcf-Dependent Activation Of Sirt1 Gene Expression

SIRT1 Collaborates with ATM and HDAC1 to Maintain Genomic Stability in Neurons

O-GlcNAcylation of SIRT1 Enhances Its Deacetylase Activity and Promotes Cytoprotection under Stress

The NAD+-dependent Protein Deacetylase Activity of SIRT1 is Regulated by Its Oligomeric Status

Sirtuins in metabolism, DNA repair and cancer

Breast Cancer Metastasis Suppressor 1 Modulates SIRT1-dependent P53 Deacetylation Through Interacting with DBC1.

The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer

KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair.

The role of SIRT1 in tumorigenesis.

SIRT1 and p53, effect on cancer, senescence and beyond.

SIRT2 promotes base excision repair by transcriptionally activating OGG1 in an ATM/ATR-dependent manner

SIRT1 regulates mitotic catastrophe via autophagy and BubR1 signaling

SIRT1 modulates cell cycle progression by regulating CHK2 acetylation−phosphorylation

ATM controls the extent of DNA end resection by eliciting sequential posttranslational modifications of CtIP

SIRT1 Deacetylates TopBP1 and Modulates Intra-S-phase Checkpoint and DNA Replication Origin Firing.

Inhibition of Nucleolar Stress Response by Sirt1: A Potential Mechanism of Acetylation-Independent Regulation of P53 Accumulation.

A synergistic action of sirtuins directly recognizes DNA breaks and potentiates DNA damage response and repair